Pharmagen Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2012
2013
Net Income before Extraordinaries
2,771.30
6,000.60
Depreciation, Depletion & Amortization
32.80
94.40
Funds from Operations
2,174.20
2,378.10
Changes in Working Capital
3.60
1,643.40
Net Operating Cash Flow
2,170.60
734.70
Capital Expenditures
94.00
56.70
Net Investing Cash Flow
174.00
56.70
Issuance/Reduction of Debt, Net
2,628.50
605.30
Net Financing Cash Flow
2,628.50
694.80
Net Change in Cash
283.90
96.60
Free Cash Flow
2,264.60
791.40
Net Assets from Acquisitions
80.00
-
Change in Capital Stock
-
125.00
About Pharmagen
View Profile
